Patent 9526724 was granted and assigned to Purdue Pharma on December, 2016 by the United States Patent and Trademark Office.
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.